Frontline intensive chemotherapy improves outcome in young, high-risk patients with follicular lymphoma: pair-matched analysis from the Czech Lymphoma Study Group Database
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Frontline intensive chemotherapy improves outcome in young, high-risk patients with follicular lymphoma: pair-matched analysis from the Czech Lymphoma Study Group Database
Authors
Keywords
-
Journal
LEUKEMIA & LYMPHOMA
Volume 58, Issue 3, Pages 601-613
Publisher
Informa UK Limited
Online
2016-09-26
DOI
10.1080/10428194.2016.1213834
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Non-Hodgkin’s Lymphomas, Version 4.2014
- (2017) Andrew D. Zelenetz et al. Journal of the National Comprehensive Cancer Network
- Analysis of dendritic cell subpopulations in follicular lymphoma with respect to the tumor immune microenvironment
- (2016) Nina Chevalier et al. LEUKEMIA & LYMPHOMA
- Autologous stem cell transplantation within vivopurged progenitor cells shows long-term efficacy in relapsed/refractory follicular lymphoma
- (2015) Luca Arcaini et al. AMERICAN JOURNAL OF HEMATOLOGY
- Prolonged clinical remissions in patients with relapsed or refractory follicular lymphoma treated with autologous stem cell transplantation incorporating rituximab
- (2015) N. L. Berinstein et al. ANNALS OF HEMATOLOGY
- Clinical impact of molecular features in diffuse large B-cell lymphoma and follicular lymphoma
- (2015) J. R. Pon et al. BLOOD
- Chemotherapy and treatment algorithms for follicular lymphoma: a look at all options
- (2015) Sara Steffanoni et al. Expert Review of Anticancer Therapy
- Rethinking Prognosis and Therapy for Follicular Lymphoma
- (2015) Caron A. Jacobson et al. JOURNAL OF CLINICAL ONCOLOGY
- Early Relapse of Follicular Lymphoma After Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone Defines Patients at High Risk for Death: An Analysis From the National LymphoCare Study
- (2015) Carla Casulo et al. JOURNAL OF CLINICAL ONCOLOGY
- Chemotherapy-free treatment in patients with follicular lymphoma
- (2015) Clémentine Sarkozy et al. Expert Review of Hematology
- PD-1 expression defines two distinct T-cell sub-populations in follicular lymphoma that differentially impact patient survival
- (2015) Z -Z Yang et al. Blood Cancer Journal
- The impact of total body irradiation on the outcome of patients with follicular lymphoma treated with autologous stem-cell transplantation in the modern era: a retrospective study of the EBMT Lymphoma Working Party†
- (2014) I. El-Najjar et al. ANNALS OF ONCOLOGY
- Newly diagnosed and relapsed follicular lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
- (2014) M. Dreyling et al. ANNALS OF ONCOLOGY
- Safety and activity of lenalidomide and rituximab in untreated indolent lymphoma: an open-label, phase 2 trial
- (2014) Nathan H Fowler et al. LANCET ONCOLOGY
- How we manage follicular lymphoma
- (2014) W Hiddemann et al. LEUKEMIA
- Indications for hematopoietic stem cell transplantation in patients with follicular lymphoma: a consensus project of the EBMT-Lymphoma Working Party
- (2013) S. Montoto et al. HAEMATOLOGICA
- R-CVP Versus R-CHOP Versus R-FM for the Initial Treatment of Patients With Advanced-Stage Follicular Lymphoma: Results of the FOLL05 Trial Conducted by the Fondazione Italiana Linfomi
- (2013) Massimo Federico et al. JOURNAL OF CLINICAL ONCOLOGY
- What Is the Role of Stem-Cell Transplantation for Follicular Non-Hodgkin Lymphoma in the Rituximab Era?
- (2013) Harry C. Schouten JOURNAL OF CLINICAL ONCOLOGY
- One Size Does Not Fit All in Follicular Lymphoma
- (2013) Caron A. Jacobson et al. JOURNAL OF CLINICAL ONCOLOGY
- Bendamustine plus rituximab versus CHOP plus rituximab as first-line treatment for patients with indolent and mantle-cell lymphomas: an open-label, multicentre, randomised, phase 3 non-inferiority trial
- (2013) Mathias J Rummel et al. LANCET
- Intensified therapy followed by autologous stem-cell transplantation (ASCT) versus conventional therapy as first-line treatment of follicular lymphoma: a meta-analysis
- (2012) Baohong Wang et al. HEMATOLOGICAL ONCOLOGY
- Impact of the use of autologous stem cell transplantation at first relapse both in naive and previously rituximab exposed follicular lymphoma patients treated in the GELA/GOELAMS FL2000 study
- (2011) S. Le Gouill et al. HAEMATOLOGICA
- Autologous Stem Cell Transplantation in Follicular Lymphoma: a Systematic Review and Meta-analysis
- (2011) M. Al Khabori et al. JNCI-Journal of the National Cancer Institute
- Validation of follicular lymphoma international prognostic index 2 (FLIPI2) score in an independent series of follicular lymphoma patients
- (2010) Luca Arcaini et al. BRITISH JOURNAL OF HAEMATOLOGY
- Rituximab maintenance for 2 years in patients with high tumour burden follicular lymphoma responding to rituximab plus chemotherapy (PRIMA): a phase 3, randomised controlled trial
- (2010) Gilles Salles et al. LANCET
- Validation, revision and extension of the Follicular Lymphoma International Prognostic Index (FLIPI) in a population-based setting
- (2009) S. A. M. van de Schans et al. ANNALS OF ONCOLOGY
- Follicular Lymphoma International Prognostic Index 2: A New Prognostic Index for Follicular Lymphoma Developed by the International Follicular Lymphoma Prognostic Factor Project
- (2009) Massimo Federico et al. JOURNAL OF CLINICAL ONCOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now